Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details) (Parenthetical)

v3.22.1
SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details) (Parenthetical) - Convertible Notes Payable One [Member]
3 Months Ended
Mar. 31, 2021
USD ($)
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Shares issued upon conversion | shares 87,697
Stock conversion amount | $ $ 1,186,176
Beneficial ownership limitations percentage 4.99%